Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 6.38
(-1.39%)
CNY 6.38
(-1.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 62.39 Million CNY | 71.17% |
| 2022 | 12.55 Million CNY | -23.88% |
| 2021 | 25.69 Million CNY | 446.98% |
| 2020 | -13.43 Million CNY | -118.63% |
| 2019 | 54 Million CNY | -37.73% |
| 2018 | 84.44 Million CNY | 0.02% |
| 2017 | 87.08 Million CNY | 7.46% |
| 2016 | 78.95 Million CNY | -6.52% |
| 2015 | 87.92 Million CNY | 134.53% |
| 2014 | 37.62 Million CNY | -63.14% |
| 2013 | 86.41 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 5.25 Million CNY | -49.89% |
| 2024 Q2 | 9.85 Million CNY | -5.86% |
| 2024 Q3 | -3.33 Million CNY | -133.17% |
| 2023 Q1 | 2.84 Million CNY | 129.1% |
| 2023 Q3 | -5.46 Million CNY | -266.49% |
| 2023 Q2 | 3.28 Million CNY | 15.35% |
| 2023 Q4 | 13.28 Million CNY | 343.05% |
| 2023 FY | - CNY | 71.17% |
| 2022 FY | - CNY | -23.88% |
| 2022 Q4 | -9.78 Million CNY | -87.69% |
| 2022 Q3 | -5.21 Million CNY | -178.17% |
| 2022 Q2 | 6.66 Million CNY | 276.39% |
| 2022 Q1 | 1.77 Million CNY | 110.97% |
| 2021 Q3 | 1.84 Million CNY | -86.1% |
| 2021 Q4 | -16.15 Million CNY | -976.21% |
| 2021 Q1 | 4.38 Million CNY | 120.08% |
| 2021 FY | - CNY | 446.98% |
| 2021 Q2 | 13.26 Million CNY | 202.4% |
| 2020 Q4 | -21.84 Million CNY | -116.41% |
| 2020 Q3 | -10.09 Million CNY | -90.76% |
| 2020 Q2 | -5.29 Million CNY | -113.03% |
| 2020 Q1 | -2.48 Million CNY | -119.09% |
| 2020 FY | - CNY | -118.63% |
| 2019 FY | - CNY | -37.73% |
| 2019 Q4 | 13 Million CNY | 633.85% |
| 2019 Q3 | -2.43 Million CNY | -111.82% |
| 2019 Q1 | 4.68 Million CNY | -70.56% |
| 2019 Q2 | 20.61 Million CNY | 339.96% |
| 2018 Q1 | 8.24 Million CNY | -63.85% |
| 2018 Q3 | 15.45 Million CNY | -56.93% |
| 2018 Q4 | 15.91 Million CNY | 2.92% |
| 2018 FY | - CNY | 0.02% |
| 2018 Q2 | 35.89 Million CNY | 335.47% |
| 2017 Q4 | 22.8 Million CNY | 1.35% |
| 2017 FY | - CNY | 7.46% |
| 2017 Q1 | 9.42 Million CNY | -49.05% |
| 2017 Q3 | 22.49 Million CNY | -17.71% |
| 2017 Q2 | 27.33 Million CNY | 189.98% |
| 2016 Q4 | 18.5 Million CNY | 54.21% |
| 2016 Q3 | 11.99 Million CNY | 0.0% |
| 2016 FY | - CNY | -6.52% |
| 2015 FY | - CNY | 134.53% |
| 2014 FY | - CNY | -63.14% |
| 2013 FY | - CNY | 0.0% |